DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+3.05%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$160M
AUM Growth
+$160M
(+9.3%)
Cap. Flow
+$10M
Cap. Flow
% of AUM
6.27%
Top 10 Holdings %
Top 10 Hldgs %
48.25%
Holding
74
New
12
Increased
22
Reduced
18
Closed
–
Top Buys
| 1 |
Turning Point Brands
TPB
|
$3.21M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$1.66M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$1.4M |
| 4 |
iShares Biotechnology ETF
IBB
|
$1.35M |
| 5 |
iShares Silver Trust
SLV
|
$1.08M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$1.64M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$1.6M |
| 3 |
TBHC
The Brand House Collective, Inc. Common Stock
TBHC
|
$1.21M |
| 4 |
SPDR Gold Trust
GLD
|
$1.15M |
| 5 |
Lowe's Companies
LOW
|
$829K |
Sector Composition
| 1 | Healthcare | 42.89% |
| 2 | Technology | 15.7% |
| 3 | Communication Services | 11.77% |
| 4 | Financials | 4.81% |
| 5 | Consumer Staples | 2.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR Gold Trust
GLD
$107B
| $11.2M | 5.75% | 63,500 -6,500 | -9% | -$1.15M |
|
|
2
Alphabet (Google) Class C
GOOG
$2.58T
| $11.2M | 5.71% | 7,600 +950 | +14% | +$1.4M |
|
|
ITCI
3
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11M | 5.6% | 427,000 +1,500 | +0.4% | +$38.5K |
|
4
Xencor
XNCR
$580M
| $7.31M | 3.74% | 188,500 -1,867 | -1% | -$72.4K |
|
5
Micron Technology
MU
$133B
| $7.21M | 3.69% | 153,500 -4,000 | -3% | -$188K |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.94M | 3.55% | 12,400 | – | – |
|
7
argenx
ARGX
$43.6B
| $6.3M | 3.22% | 24,000 | – | – |
|
8
AbbVie
ABBV
$372B
| $5.61M | 2.87% | 64,000 +4,850 | +8% | +$425K |
|
9
Incyte
INCY
$16.5B
| $5.38M | 2.75% | 60,000 +1,500 | +3% | +$135K |
|
10
Oracle
ORCL
$635B
| $5.08M | 2.6% | 85,000 | – | – |
|
|
11
Advanced Micro Devices
AMD
$264B
| $4.51M | 2.31% | 55,000 -20,000 | -27% | -$1.64M |
|
|
12
VanEck Gold Miners ETF
GDX
$19B
| $4.31M | 2.2% | 110,000 +42,500 | +63% | +$1.66M |
|
13
Bank of America
BAC
$376B
| $4.04M | 2.06% | 167,500 | – | – |
|
14
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4M | 2.05% | 27,500 | – | – |
|
15
AT&T
T
$209B
| $3.85M | 1.97% | 135,000 +10,000 | +8% | +$285K |
|
16
Verizon
VZ
$186B
| $3.81M | 1.95% | 64,000 +6,500 | +11% | +$387K |
|
17
iShares Gold Trust
IAU
$50.6B
| $3.6M | 1.84% | 200,000 | – | – |
|
|
18
Turning Point Brands
TPB
$1.79B
| $3.48M | 1.78% | 124,750 +115,000 | +1,179% | +$3.21M |
|
19
Fresenius Medical Care
FMS
$15.1B
| $3.08M | 1.57% | 72,500 +6,000 | +9% | +$255K |
|
20
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $3.05M | 1.56% | 55,000 +12,500 | +29% | +$692K |
|
21
Amgen
AMGN
$155B
| $2.86M | 1.46% | 11,250 -500 | -4% | -$127K |
|
22
Citigroup
C
$178B
| $2.8M | 1.43% | 65,000 | – | – |
|
|
SGEN
23
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.54M | 1.3% | 13,000 -1,000 | -7% | -$196K |
|
24
Bristol-Myers Squibb
BMY
$96B
| $2.5M | 1.28% | 41,500 +1,500 | +4% | +$90.4K |
|
|
AOD
25
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.27M | 1.16% | 286,417 +1,500 | +0.5% | +$11.9K |
|